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Introduction: Both guided online and individual face-to-face cognitive behavioral therapy for insomnia
(CBT-I) are effective in improving insomnia symptoms and sleep efficiency. Little is known about the
underlying mechanisms generating this effect. The present study tests the assumption that pre-sleep
arousal, sleep-related worry and dysfunctional beliefs about sleep are mediators in the effect of cogni-
tive behavioral treatment for insomnia.
Methods: A secondary analysis was performed on data previously collected from a randomized
controlled trial (N ¼ 90). In this trial, participants were randomized to either a face-to-face CBT-I con-
dition, an internet-delivered CBT-I condition, or a wait-list group. This article reports on the efficacy of
these interventions on pre-sleep arousal, sleep-related worry, and dysfunctional beliefs. Furthermore, we
investigated whether these measures mediated the treatment effect on insomnia severity and sleep
efficiency.
Results: Both treatment modalities were efficacious for these cognitive measures; however, face-to-face
treatment showed superiority over the online treatment. All three cognitive measures mediated the
effect on insomnia severity. Sleep-related worry and pre-sleep arousal mediated the effect on sleep ef-
ficiency, but dysfunctional beliefs did not.
Conclusion: Overall, these results point toward the importance of cognitive processes in the treatment of
insomnia, implying that psychological treatments for insomnia may best be guided by (also) targeting
these cognitive processes.
© 2018 Elsevier B.V. All rights reserved.1. Introduction
Chronic insomnia is a disorder with a prevalence of 6e10% in the
general adult population [1]. Insomnia is characterized by dissat-
isfaction with sleep quantity and quality, coupled with difficulties
getting to sleep and/or maintaining sleep for at least three months
for three nights per week. These sleep problems need to signifi-
cantly affect daytime functioning in order to satisfy the formal
criteria of the sleep disorder insomnia [2].
Insomnia has a serious negative impact on quality of life [3] and
comes with high societal costs [4]. Insomnia is related to several
daytime complaints such as problems with memory andl Psychology, University of
Netherlands.concentration [5], and is a risk factor for cardiovascular disease [6],
and psychiatric disorders such as anxiety and depressive disorders
[7].
Cognitive behavioral therapy for insomnia (CBT-I) is currently
the treatment of choice for insomnia [8,9]. CBT-I is more effective in
the long term than sleep medication [10,11]. Furthermore, several
meta-analyses have demonstrated large treatment effects for CBT-I
[12e14]; for instance, van Straten et al., [14] reported a wait-list
controlled effect size of d ¼ 1.0 for insomnia severity.
Unfortunately, there is a shortage of trained CBT-I therapists
[15]. For this reason, CBT-I is now increasingly provided via the
internet where therapist time may be reduced, and less training
may be required. Guided internet-delivered CBT-I is effective with
moderate to large treatment effects (Cohen's d ¼ 0.6e1.1) [16], and
is preferably offered with some form of guidance [17].
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ment effects compared to regular face-to-face CBT for other somatic
and psychological disorders (Cohen's d ¼ 0.01/Hedges g ¼ 0.05)
[18,19]. However, for insomnia, the findings on the comparative
efficacy of CBT-I between guided online and face-to-face CBT-I are
scarce and inconclusive. A recent study of Bl€om and colleagues [20]
showed no difference in effect between guided-online and face-to-
face CBT-I (Cohen's d ¼ 0.1 on insomnia severity. In our work, we
compared guided-online and face-to-face treatment to a wait-list
control condition. Compared to the wait-list, we observed large
treatment effects for guided-online and face-to-face treatment on
insomnia severity (d ¼ 1.0/d ¼ 2.3) and sleep efficiency (d ¼ 0.6/
d¼ 0.8). In this trial, face-to-face CBT-I was superior over the online
condition on insomnia severity (Cohen's d ¼ 0.9) [21].
Despite these generally effective treatments, a central problem
remains that even after the most effective treatments, 20e30% of
insomnia suffers still do not achieve a therapeutic response [5]. In
order to improve treatments, it is essential to knowmore about the
underlying or maintaining factors that bring about the treatment
effects [22]. In recent years there have been some attempts to find
mechanisms and cognitive processes appear to be among the most
promising candidates for explaining the efficacy of insomnia
treatments [23].
Several models have put forward the importance of cognitive
processes in insomnia (eg, [24,25]). The cognitive model of Harvey
[26] is specifically focused on this aspect. The model posits that an
interplay between dysfunctional beliefs and safety behaviors leads
to excessive negatively toned cognitive activity about sleep (such as
worry). The excessive negatively toned cognitive activity about
sleep then leads to arousal and distress, selective attention, and
increasedmonitoring of sleep-related threats (all interrelated in the
model). These processes build up to a distorted perception of the
deficit, which in turn causes the actual impairment in sleep and
daytime functioning. In the cognitive model, all these processes are
supposed to play a unique part in maintaining the insomnia dis-
order. For this paper, we focus on three parts of the cognitive model
of Harvey: dysfunctional beliefs, excessive negatively toned
cognitive activity, and ‘arousal and distress.’ If these cognitive
processes are indeed perpetuating factors of insomnia, amelio-
rating these should lead to a decline of the insomnia complaints as
well. Stated differently, if these cognitive processes are important
treatment mechanisms, they will mediate the treatment effect for
insomnia disorder.
Recently, several articles have appeared that report on cognitive
processes as mediators in the CBT-I treatment of insomnia, with
inconsistent findings. For example, it was observed that a decline in
insomnia severity was mediated by a decline in dysfunctional be-
liefs about sleep [27e31]; however, Okajima and colleagues did not
observe this mediational effect [32]. Furthermore, we found that
dysfunctional beliefs mediated the effects of CBT-I for sleep effi-
ciency [30] although Espie and colleagues did not observe this
relationship [28].
For arousal and excessive negatively toned cognitive activity, the
evidence formediators is scarcer. Pre-sleep arousal was observed to
mediate both the decline in insomnia severity and sleep efficiency
by Vincent and Walsh [33]; however, Sunnhed and Jansson-
Fr€ojmark [34] found no evidence for pre-sleep arousal as a medi-
ator for insomnia severity. For negatively toned cognitive activity,
we were only able to identify two studies that conducted analyses
on the relationship of the decline in sleep-related worry and the
decline of insomnia severity; one study indeed identified sleep-
related worry as a mediator [29], while the other study showed
an association between the two constructs [34].
To conclude, even though several research groups on both a
theoretical level and on an empirical level state the importance ofcognitive processes in insomnia, there have been very few studies
that investigated whether the changes in these cognitive processes
indeed mediate the treatment effects of CBT-I. The limited number
of studies that have been published report inconclusive results,
especially for pre-sleep arousal and sleep-related worry. To extend
this literature, we performed a secondary data-analysis on an
earlier randomized controlled trial comparing online to face-to-
face treatment for insomnia [21]. In line with the results of that
trial and the data about cognitive processes, we predicted:
1. Both face-to-face and guided internet-delivered CBT-I are more
effective than a wait-list on dysfunctional beliefs about sleep,
negatively toned cognitive activity (sleep-related worry),
arousal and distress (pre-sleep arousal);
2. Face-to-face CBT-I is more effective than guided internet-
delivered CBT-I on pre-sleep arousal, dysfunctional beliefs
about sleep, and sleep-related worry;
3. Pre-sleep arousal, dysfunctional beliefs about sleep, and sleep-
related worry mediate the treatment effects of CBT-I on
insomnia severity and sleep efficiency.2. Method
2.1. Participants
We performed a secondary data analysis on the study of Lancee
and colleagues [21]. The primary study was approved by the in-
ternal Ethical Review Board of the University of Amsterdam and
was registered at Clinicaltrials.gov (NCT01955850). In this study,
participants were recruited through a popular-science website
from April 2013 to January 2014 (www.insomnie.nl) and through a
Facebook campaign. The actual registration for the study took
place in October 2013 and January 2014. A total of 183 participants
completed the informed consent and the online questionnaires.
Inclusion criteria for the study were as follows: (1) insomnia
disorder according to the DSM-5 (difficulty initiating sleep and/or
staying asleep; consequences during the day) [2]; (2) Insomnia
Severity Index (ISI) score of 10 or higher [35]; (3) Sleep onset la-
tency and/or wake after sleep onset for at least 30 min for at least
three nights per week; and (4) at least 18 years or older. Exclusion
criteria were: (1) sleep apnea (measured by a subscale of the
SLEEP-50 cutoff > 15) [36]; (2) shift-work; (3) pregnancy; (4)
earlier CBT-I; (5) start of psychotherapy in the past six months; (6)
major depressive disorder based on the Structured Clinical Inter-
view for DSM-IV disorders (SCID-I assessment via telephone); (7)
alcohol abuse (more than three units alcohol per day for at least 21
days per month); (8) marijuana use more than once a week; (9)
self-reported diagnosis of schizophrenia or psychosis; and (10)
current suicidal plans.
Following these criteria, the online assessment resulted in the
exclusion of 47 participants from the study. The remaining partic-
ipants (N ¼ 136) were invited to a telephone-screening interview
for insomnia (DSM-5) and depression (SCID-I), conducted by a
psychologist. Another 46 participants were excluded at this stage
(see Fig. 1 for a flowchart). Of the final sample (N ¼ 90), 81.1%
(n ¼ 73) was female, and participants had a mean age of 41.6 years
old (SD ¼ 13.7). About a third of the participants used prescribed
sleep medication (n ¼ 28; 31.1%), virtually no participants were
currently in psychological treatment (n ¼ 3; 3.3%), about half lived
together with a partner (n ¼ 48; 53.3%), most were employed
(n ¼ 74; 82.2%), and about half had insomnia for more than five
years (n ¼ 47; 52.2%). No differences between the groups on the
demographic variables were observed at baseline. The participants
were randomly distributed over the online treatment condition
Interested in study/ started with 
online screener (n = 183)
Screening via telephone (n = 136)
Excluded  (n = 47): 
- Shift work (n = 2)
- Apnea (n = 18)
- Marijuana abuse (n = 1)
- Start psychotherapy < 6 months (n = 8)
- Insomnia < 3months (n = 2)
- Insomnia  no impact on daily life (n = 6)
- Insomnia < 3 nights a week (n = 2)
- Schizophrenia/psychosis (n = 1)
- Did not complete online screener (n = 7)
Excluded (n = 46): 
- Unable to reach (n = 13)
- MDD according to SCID-I (n = 9) 
- Not able to attend treatment site (n = 6) 
- Earlier CBT-I (n = 6)
- Did not complete sleep diary (n = 4)
- Holiday ≥ 3 weeks (n = 3)
- No insomnia disorder (n = 2)
- Apnea (n = 2)
- Pregnant (n = 1) 
Randomized (n = 90)
Face-to-Face (n = 30)
Post-test, n = 29(96.7%)     
3-month, n = 29 (96.7%)     
6-month, n = 26 (86.7%)     
Online  (n = 30) Waiting-list (n = 30)
Post-test, n = 26 (86.7%)    
3-month, n = 21 (70.0%)    
6-month, n = 21 (70.0%)    
Post-test, n = 26 (86.7%)    
Fig. 1. Flowchart.
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wait-list condition (n ¼ 30).
2.2. Power
The sample size of the primary study was based on a power
analysis for a within-between interaction effect size of f ¼ 0.20
(alpha of 0.05 and a power of 0.80); for the analysis to detect this
effect size, 22 participants per group were required. To account for
prospective dropout, we recruited 30 participants per condition.
3. Materials
3.1. Mediators
Dysfunctional beliefs about sleep were measured using the 16-
item Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS-
16). The DBAS-16 has good internal consistency (a ¼ 0.77 e 0.79;
a ¼ 0.82 in this sample) and good test-retest reliability (r ¼ 0.83)
[37]. The sum of the DBAS score was averaged so that the total score
ranged from 0 (no dysfunctional beliefs) to 10 (severe dysfunctional
beliefs).
Sleep-related worry was measured by the Anxiety and Preoc-
cupation about Sleep Questionnaire (APSQ). The APSQ is a 10-item
questionnaire with items that can be answered from 1 (strongly
disagree) to 5 (strongly agree), with higher scores indicating more
sleep-related worry. This self-report questionnaire has good inter-
nal consistency (a ¼ 0.91; a ¼ 0.84 in this sample) and is a valid
measure to assess worry in people with insomnia [38].
Sleep-related arousal was measured with the Pre-sleep Arousal
Scale (PSAS) [39]. The PSAS consists of 16 items that range from 1
(‘not at all’) to 5 (‘extremely’), higher scores indicating more
arousal. Originally, the PSAS consists of two 8-item subscales con-
cerning either cognitive or somatic arousal (a ¼ 0.76e0.81). In
correspondence with Vincent and Walsh [33], we report in this
study on the sum-score of the PSAS (a ¼ 0.84 in this sample).
3.2. Dependent variables
Insomnia symptoms were measured using the Dutch version
of the 7-item Insomnia Severity Index (ISI). This questionnaire
generally has a good internal consistency (a ¼ 0.74) and is a valid
measure to assess insomnia [40]. ISI items are answered on a 5-
point Likert scale (range 0e4); the total score ranges from 0 to28, higher scores indicating higher severity. As we reported in
the primary study [21], the reliability of the ISI was low due to
the first item of the questionnaire (about difficulty falling asleep
(a ¼ 0.22 with an a ¼ 0.57 without the first item). Furthermore,
there is considerable conceptual overlap between the last item of
the ISI (‘how worried/distressed are you about your current sleep
problem’) and items from the APSQ. Therefore, we performed the
mediation analyses for the ISI without items one and seven (the
resulting scale had an a ¼ 0.54). Please see Footnote 1 for in-
formation about the mediation analyses with these items
included.
All participants kept a Dutch translation of the Consensus Sleep
Diary [41] for seven consecutive days. In this diary, they logged
several aspects of their sleep. For this report, only the sleep effi-
ciency (SE) is relevant. Sleep efficiency was calculated by:
SE ¼ [TST/TIB]  100), where TST ¼ total sleep time and TIB ¼ time
in bed.3.3. Other
Depressive symptoms were measured with the Dutch trans-
lation of the Centre of Epidemiological Studies Depression scale.
The 20-item CES-D ranges from ‘0’ (no depressive symptoms) to
‘60’ (high depressive symptoms). The scale has shown strong reli-
ability in both the original and Dutch language (a ¼ 0.79e0.92;
a ¼ 0.88 in this sample) [42,43].3.4. Intervention
In both the online and face-to-face CBT-I we employed a
multicomponent treatment for insomnia that packaged: (a)
psycho-education; (b) progressive muscle relaxation; (c) sleep hy-
giene and stimulus control; (d) sleep restriction (ie, restricting time
in bed to actual sleeping time); (e) cognitive exercises (ie, chal-
lenging the misconceptions about sleep) [44]. The online treat-
ment, first described by Lancee and colleagues [45], comprised of
six weekly sessions, and participants received feedback by e-mail
up to eight weeks. Feedback was provided by masters level psy-
chology students, supervised by the first author. In the face-to-face
condition, six 45-minute individual treatment sessions were
administered by a psychologist specialized in insomnia treatment.
For a more elaborate description of the intervention and the sleep
restriction protocol, please see [21].
Change score 

















Fig. 2. Fig. 2a: path c is the total effect of group on the outcome variables without the
influence of the mediator variable. Fig. 2b, path a is the effect of group on the mediator
variable, path b is the effect of the mediator on the outcome variable. Path ab is the
indirect effect (or mediation effect). Path c’ is the effect of the group controlling for the
mediator variables.
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Participants who met the study criteria first received a short in-
formation leaflet and an informed consent form with pertinent in-
formation about the study. After digitally signing the informed
consent, participants completed the online questionnaires and sleep
diary (for seven days). Subsequently, participants were randomly
assigned to theguided-online treatment condition (onlineCBT-I), the
individual face-to-face treatment condition (face-to-face CBT-I), or
thewait-list condition. Neither experimenters nor participants were
blind to treatment allocation. Twelve weeks after the randomization
and start of the study (about four weeks after completing the treat-
ment), all participants received a posttest assessment with the same
questionnaires and the same seven-day sleep diary as the pretest.
After that, participants in the wait-list condition received online
treatment for insomnia. Participants in the two active treatment
conditions also received measurements three and six months after
the post-test (FU1 and FU2). For a more elaborate description of the
study procedure, please see [21].
3.6. Statistical analyses
Generalizedmixed (multilevel) regression analyseswere carried
out to evaluate the effects of the two interventions compared to the
wait-list at post-test and their sustained effects over the course of
the two follow-up assessments. Regular linear mixed regression
with an identity link was used for normally distributed data (APSQ,
DBAS, and pre-sleep arousal at post-test), negative binomial
regression with a log link in case of skewness (pre-sleep arousal at
follow up assessments). Data were analyzed in accordance with the
intention-to-treat principle [46]. Assuming data to be missing as
random, we used an unstructured covariance structure as the best
fitting model for the data.
In the parent study [21] we observed that there were baseline
differences in depression symptoms between the face-to-face and
the wait-list condition. Furthermore, in the online condition, high
depression scores were related to non-response to the post-test
in the online condition. For this reason, short-term effects (pre-
versus post-test) were examined using baseline depression scores
(CES-D) [42]. Long-term effects (post-assessment-FU1-FU2) were
examined using both the CES-D baseline and APSQ at baseline as
covariates because baseline APSQ scores predicted non-response
to the follow-up measurements in the face-to-face intervention
group. Effect sizes reported are within-group Cohen's d effect
sizes (based on multilevel estimated baseline and post-test means
and pooled standard deviations at baseline) and between-group
Cohen's d effect sizes (calculated by dividing the estimated dif-
ference in change scores between two groups by the pooled
standard deviations at baseline; [47].
For the mediation analyses, we decided to collapse the online
and face-to-face CBT-I condition. We did not expect specific
mediation effects for the online vs. face-to-face condition since
two treatments employed the same intervention modules.
Furthermore, collapsing the two conditions increased our statis-
tical power. We do report the ‘un-collapsed’mediation analyses in
the Results section and Supplemental Table S6. We used the
PROCESS tool in SPSS [48]. The PROCESS tool uses a bootstrapping
method, which is a non-parametrical procedure that generates an
estimate of the sample based on several re-samples. The reason
for using this bootstrapping procedure was because this proced-
ure does not require the sampling distribution of the indirect ef-
fect to be normally distributed. Mediation was tested by
evaluating the 95% confidence interval of the indirect effect (see
Fig. 2 for the mediation models). We employed a procedure
similar to the one we described in our earlier study [30]. For thecurrent analyses, we used n ¼ 50.000 bootstrap re-samples and
used change scores (pre-post) for both the mediator and the
dependent variable. Moreover, because of baseline differences, we
used baseline depression scores (CES-D) as a covariate in all the
mediation analyses. We calculated the effect size of the indirect
effect with 1 e c’/c. With this formula, the proportion of the effect
of the independent variable on the dependent variable, which is
accounted for by the mediator, is calculated. Possible values lie
between 0 and 1 [49].
4. Results
4.1. Multilevel analyses
At post-test, multilevel regression analyses showed significant
Condition  Time interactions for dysfunctional beliefs, F (2,
78) ¼ 25.69, p < 0.001; sleep-related worry, F (2, 77) ¼ 19.90,
p < 0.001; and pre-sleep arousal, F (2, 78) ¼ 18.88, p < 0.001.
Specifically, participants undergoing face-to-face treatment
showed larger decreases than wait-list participants in sleep related
worry; F (1, 54) ¼ 54.73, p < 0.001; in pre-sleep arousal, F (1,
53) ¼ 36.25, p < 0.001; and dysfunctional beliefs, F (1, 53) ¼ 74.12,
p < 0.001. Online treatment also outperformed the wait-list con-
dition on all variables: sleep related worry, F (1, 49) ¼ 9.93,
p ¼ 0.003; pre-sleep arousal, F (1, 48) ¼ 12.63, p ¼ 0.001; and
dysfunctional beliefs, F (1, 49)¼ 13.28, p¼ 0.001. Additionally, face-
to-face treatment outperformed the online treatment on dysfunc-
tional beliefs, F (1, 54) ¼ 8.91, p < 0.01; on sleep-related worry, F (1,
53) ¼ 7.37, p < 0.01; and on pre-sleep arousal, F (1, 55) ¼ 4.42,
p ¼ 0.04. Please see Fig. 3 and Tables 1 and 2 for the estimated
means and the corresponding Cohen's d's (and Supplemental
Table S1eS4 for the observed means and the multilevel regres-
sion coefficients). At follow-up, improvements in the two treatment
effects were stable: no significant time effects or Condition  Time
interaction effects were found when comparing post-assessment
vs. follow-up 1 vs. follow-up 2: sleep-related worry, F (2,
46) ¼ 0.20, p ¼ 0.818; dysfunctional beliefs, F (2, 49) ¼ 0.30,
p ¼ 0.742; and pre-sleep arousal, F (2, 43) ¼ 0.29, p ¼ 0.75. The
differences between face-to-face treatment and online treatment
remained significant over time from post-test to the second follow-
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Pre-sleep arousal (PSAS)
f2f online wl
Fig. 3. Dysfunctional beliefs (DBAS), sleep-related worry (APSQ) and pre-sleep arousal
(PSAS) scores on all time points for face-to-face, online and wait-list groups. The figure
is based on the estimated means. Error bars represent SEM.
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44) ¼ 20.295, p < 0.001, and dysfunctional beliefs, F (1, 50) ¼ 16.47,
p < 0.001.4.2. Single mediation analyses
We conducted mediation analyses with the pre-post change
scores of the Insomnia Severity Index (ISI) with sleep efficiency (SE)
as dependent variables. The pre-to-post change scores of the
dysfunctional beliefs (DBAS), sleep-related worry (APSQ), and pre-
sleep arousal (PSAS) were included as mediator variables in the
analyses, and the severity of depressive symptoms (CES-D) was
added as a covariate. Please see Supplemental Table S5 for the zero-
order baseline correlations.1 As described in the ‘measurements’ section we decided to use the ISI without
item 1 & 7. We also ran the mediation analysis with either item 1 or 7 or all items
included. The bootstrap CI changed slightly but the observed effects stayed within
the 95 CI indicating that the observed effects were robust. The same applies, for the
mediation analyses with the two Pre-arousal subscales (cognitive/somatic e with
the exception that the somatic subscale was no mediator for sleep efficiency). We
also carried out reciprocity mediation analyses (ISI/SE as mediator and DBAS/Pre-
arousal/APSQ as outcomes). In these analyses we found roughly the same but
smaller mediation effects, indicating bi-directional relationships: DBAS was medi-
ated by the ISI (46% variance explained) but not by SE. APSQ was mediated the by
ISI (42%) and SE (44%). Pre-arousal was mediated by the ISI (44%) but not SE.As can be seen in Table 3, dysfunctional beliefs, b ¼ 3.57, 95% BI
[2.42, 4.97] (83% of the effect explained by the mediator), sleep-
related worry, b ¼ 2.46, 95% BI [1.34, 3.97] (58% explained vari-
ance), and pre-sleep arousal, b ¼ 2.84, 95% BI [1.76, 4.28] (66%
explained variance) mediated the treatment effects of CBT-I on
insomnia severity. A decline in these cognitive measures was
related to a decline in insomnia severity.1 Additionally, sleep-
related worry, b ¼ 5.51, 95% BI [2.11, 10.06] (79% explained vari-
ance) and pre-sleep arousal, b ¼ 3.33, 95% BI [0.25, 7.52] (48%
explained variance) mediated the effects on sleep efficiency; the
change in dysfunctional beliefs did not. A decline in sleep-related
worry and pre-sleep arousal was related to an increase in sleep
efficiency.
We also carried out the mediation analyses for the separate
interventions (ie, non-collapsed; online vs. wait-list and face-to-
face vs. waitlist). The same set of variables emerged as significant
mediators, with the only exception that in the online condition,
sleep efficiency was now mediated by dysfunctional beliefs and
sleep-related worry but not by pre-sleep arousal. These mediation
analyses can be found in Supplemental Table S6.
4.3. Multiple mediation analyses
In the multiple mediation analyses, all mediator variables were
included in a single model (Table 3). For the Insomnia Severity
Index, only dysfunctional beliefs and pre-sleep arousal remained as
significant mediators. The three cognitive variables together
explained 97% of the variance, b¼ 4.40, 95% BI [3.07, 6.19]. For sleep
efficiency, only sleep-related worry survived the multiple media-
tion analyses. The three variables together explained 71% of the
variance, b ¼ 4.93, 95% BI [0.58, 10.11].
5. Discussion
This study examined the efficacy of face-to-face and guided
online CBT-I on dysfunctional beliefs, sleep-related worry, and pre-
sleep arousal and whether these cognitive processes mediate the
treatment effect. As expected, we found a strong effect for both
interventions: participants in the face-to-face and online CBT-I
conditions reported moderate-to large decreases in dysfunctional
beliefs, pre-arousal, and sleep-related worry compared to the wait-
list. The observed treatment effects of CBT-I on these cognitive
measures are in line with previous research [27,30,34,50e52].
Furthermore, the effects on pre-arousal, sleep-relatedworry and
dysfunctional beliefs were superior for face-to-face CBT-I compared
to online CBT-I. This is in line with the primary study that
demonstrated the superiority of face-to-face treatment over online
treatment [21]. Whether face-to-face treatment is generally better
than online treatment for insomnia remains an open, empirical
question. As discussed in the introduction, there have been other
sleep-related studies that did not observe differences between
these two modalities [53], and relatedly, a recent meta-analysis
found no difference between online and face-to-face treatment
for psychiatric and somatic disorders [19].
Next, we considered the mediating role of sleep-related beliefs,
negative cognitive activity, and pre-sleep arousal on insomnia
severity and sleep efficiency (with both treatment conditions
collapsed). For insomnia severity, as expected, pre-arousal (66%
explained variance), sleep-related worry (58%) and dysfunctional
beliefs (83%) all mediated the effect of treatment on insomnia
severity: A larger decline in these measures meant a larger decline
in insomnia severity. In the multiple mediation analyses, only
dysfunctional beliefs and pre-sleep arousal remained mediators of
the effects. These findings were in general consistent with the
extant literature. For dysfunctional beliefs, five earlier studies also
Table 1
Pre- and (estimated) post-test means with corresponding between-group Cohen's d effect sizes for the online, face-to-face (f2f), and wait-list (wl) condition.
Pre-test means (SE) Post-test means (SE) Cohen's d
f2f Online WL f2f Online WL f2f  online f2f  WL Online  WL
Dysfunctional beliefs (DBAS) 5.41 (0.24) 5.56 (0.22) 5.50 (0.28) 2.68 (0.29) 4.10 (0.31) 5.35 (0.31) 1.0** 1.8*** 1.0**
Sleep-related worry (APSQ) 35.13 (1.08) 34.53 (1.26) 35.87 (1.33) 22.12 (1.51) 26.92 (1.58) 33.40 (1.61) 0.8** 1.6*** 0.7**
Pre-sleep arousal (PSAS) 38.77 (1.93) 41.93 (1.31) 43.90 (1.94) 28.81 (1.71) 35.87 (1.90) 43.06 (1.83) 0.4* 0.9*** 0.6**
Note. * ¼ p < 0.05; ** ¼ p < 0.01; *** ¼ p < 0.001. APSQ ¼ Anxiety and Pre-occupation about Sleep Questionnaire; DBAS ¼ Dysfunctional Beliefs and Attitude about Sleep scale;
PSAS ¼ Pre-Sleep Arousal Scale. Please see Supplemental Table S1 for the observed means and Supplemental Table S3 for the multilevel regression coefficients. f2f ¼ Face-to-
face; WL ¼ Wait-list.
Table 2
Estimated three- and 6-month follow-up means with corresponding Cohen's d scores for the online and face-to-face (f2f) condition.
3-month FU means (SE) 6-month FU means (SE) Cohens'd f2f  online
f2f Online f2f Online 3-month 6-month
Dysfunctional beliefs (DBAS) 2.80 (0.26) 4.18 (0.30) 2.71 (0.31) 4.31 (0.34) 1.0*** 1.1***
Sleep-related worry (APSQ) 20.05 (1.57) 26.79 (1.77) 20.73 (1.50) 26.49 (1.64) 1.1** 1.0**
Pre-sleep arousal (PSAS) 27.24 (1.40) 37.22 (1.93) 28.33 (1.65) 37.19 (2.13) 0.8*** 0.6***
Note. * ¼ p < 0.05; ** ¼ p < 0.01; *** ¼ p < 0.001. APSQ ¼ Anxiety and Pre-occupation about Sleep Questionnaire; DBAS ¼ Dysfunctional Beliefs and Attitude about Sleep scale;
PSAS ¼ Pre-Sleep Arousal Scale. Please see Supplemental Table S2 for the observed means and Supplemental Table S4 for the multilevel regression coefficients. f2f ¼ Face-to-
face; WL ¼ Wait-list.
J. Lancee et al. / Sleep Medicine 54 (2019) 86e93 91found that it mediated CBT-I effect on insomnia severity [27e31]
and only one did not [32]. For sleep-related worry, there was one
study identifying it as a mediator [29] and one study that found
associations between a decline in sleep-related worry and
insomnia severity [34]. For pre-arousal findings appear inconclu-
sive, with one study reporting the effect [33] and one not [53].
For sleep efficiency, our results were somewhat mixed. In line
with our hypotheses, the increase in sleep efficiency was mediated
by a decline in sleep-related worry (explaining 79% of the variance)
and pre-arousal (48%). The latter was also a mediator in an earlier
study [33], but was absent in another [53]. Sleep-related worry was
the only mediator that survived the multiple mediation analyses.
We could not identify any earlier study that investigated it as a
mediator for sleep efficiency, but the results are in line with earlier
work with insomnia severity as an outcome [29]. Dysfunctional
beliefs did not mediate the treatment effect of sleep efficiency in
our sample, in contrast to our own earlier work [30], but in line
with Espie and colleagues [28]. A possible reason why the findings
on sleep efficiency are less consistent may be that the magnitude of
its treatment effect is smaller than for insomnia severity and that
mediation is, therefore, harder to detect.Table 3




variable on mediator (a)
Effect of mediator on
dependent variable (b)
Single mediator analyses
DBAS ISI b ¼ 2.33, t ¼ 5.87*** b ¼ 1.53, t ¼ 6.76***
APSQ ISI b ¼ 9.80, t ¼ 5.08*** b ¼ 0.25, t ¼ 4.87***
PSAS ISI b ¼ 11.54, t ¼ 5.34** b ¼ 0.25, t ¼ 5.53***
DBAS SE b ¼ 2.41, t ¼ 5.69*** b ¼ 1.37, t ¼ 1.46ns
APSQ SE b ¼ 9.34, t ¼ 4.70*** b ¼ 0.59, t ¼ 3.10**
PSAS SE b ¼ 10.53, t ¼ 4.60*** b ¼ 0.31, t ¼ 1.83∞
Multiple mediator analyses
DBAS ISI b ¼ 2.33, t ¼ 5.87*** b ¼ 1.09, t ¼ 3.93***
APSQ ISI b ¼ 9.80, t ¼ 5.08*** b ¼ 0.03, t ¼ 0.49ns
PSAS ISI b ¼ 11.54, t ¼ 5.34** b ¼ 0.13, t ¼ 2.82**
DBAS SE b ¼ 2.41, t ¼ 5.69*** b ¼ 0.87, t ¼ 0.71ns
APSQ SE b ¼ 9.34, t ¼ 4.70*** b ¼ 0.66, t ¼ 2.45*
PSAS SE b ¼ 10.53, t ¼ 4.60*** b ¼ 0.08, t ¼ 0.42ns
Note. Independent variable ¼ ‘Group’; ∞ ¼ p < 0.1; * ¼ p < 0.05; ** ¼ p < 0.01; **
DBAS ¼ Dysfunctional Beliefs and Attitudes about Sleep scale; ISI ¼ Insomnia Severity InBefore further discussing the implications of these results we
would first like to turn toward possible limitations of this study.
First and foremost, this study was not set up as a mediation study.
As a consequence, we did not have any midpoint measurements,
and therefore we have no information on temporality or causality.
Therefore, it is unclear whether the changes in the mediators
preceded the changes in insomnia symptoms. This is especially
notable since reciprocity tests showed that the cognitive measures
and the two outcomes had bidirectional relationships (but smaller
if the cognitive measures were inserted as outcomese see Footnote
1). It is critical to identify the direction of these temporal re-
lationships and, accordingly, there is a clear need for studies that
are specifically designed to investigate these mediators.
Second, since we used a dataset of a study not specifically set up
for testing mediation analyses, we were only able to test a sub-
sample of cognitive measures. For instance, we did not include a
measure for selective attention and monitoring nor did we include
safety behaviors, both of which feature in the cognitive model of
Harvey [26]. Some earlier studies have found selective attention
[29] and safety behavior to be mediators [30] in the treatment ef-
fect, but other studies did not [31]. In any case, only two studiess mediators of online CBT for insomnia outcomes.
Indirect effect (ab), [95% BI] Direct effect (c') Total effect (c)
b ¼ 3.57, [2.42, 4.97] b ¼ 0.73, t ¼ 0.78ns b ¼ 4.30, t ¼ 4.36***
b ¼ 2.46, [1.34, 3.97] b ¼ 1.84, t ¼ 1.84ɸ b ¼ 4.30, t ¼ 4.36***
b ¼ 2.84, [1.76, 4.28] b ¼ 1.47, t ¼ 1.49ns b ¼ 4.30, t ¼ 4.36***
b ¼ 3.30, [1.26, 8.28] b ¼ 3.66, t ¼ 0.92ns b ¼ 6.96, t ¼ 2.13*
b ¼ 5.51, [2.11, 10.06] b ¼ 1.45, t ¼ 0.41ns b ¼ 6.96, t ¼ 2.13*
b ¼ 3.33, [0.25, 7.52] b ¼ 3.63, t ¼ 0.99ns b ¼ 6.96, t ¼ 2.13*
b ¼ 2.54, [1.22, 4.09] b ¼ 0.10, t ¼ 0.11ns b ¼ 4.30, t ¼ 4.36***
b ¼ 0.29, [1.02, 1.48]
b ¼ 1.57, [0.37, 3.14]
b ¼ 2.10, [8.70, 3.77] b ¼ 2.03, t ¼ 0.52ns b ¼ 6.96, t ¼ 2.13*
b ¼ 6.12, [1.16, 12.85]
b ¼ 0.91, [3.16, 5.27]
* ¼ p < 0.001; APSQ ¼ Anxiety and Pre-occupation about Sleep Questionnaire;
dex; PSAS ¼ Pre-sleep arousal scale; SE ¼ Sleep efficiency.
J. Lancee et al. / Sleep Medicine 54 (2019) 86e9392[29,31] have looked at the full interplay of all the constructs of the
cognitive model. These two studies provided a fascinating insight
into the model, but both studies had specific limitations. Harvey et
al. [29]. did not include an inactive comparison condition, and
Norell-Clarke et al. [31] did not observe treatment effects on several
cognitive measures (possibly because of the active control condi-
tion and the comorbid sample). In our opinion, future studies
should ideally include all relevant variables and employ a design
that is optimally suited to investigate mediational effects and al-
lows for a comprehensive test of the full model.
Third, we decided to collapse the two treatment conditions for
reasons of statistical power and because we did not expect differ-
ential mediation effects between the two conditions (we expected
the same mediators in online and face-to-face condition). Even
though we deem it a plausible argument, the findings may be
confounded bymode of delivery. This, however, seems unlikely: the
mediation outcomes generally followed the same patternwhen the
conditions were analyzed separately (Supplemental Table S6).
Another limitation of the present study is that the sample
consisted of self-referred patients who were recruited online.
Possibly, this convenience sample may differ from patients who
seek help from their general practitioner or from other clinical
groups, which would limit the external validity of the present
study. Furthermore, we did not include objective measures such as
polysomnography and did not include an active control condition.
The latter omission leaves open the question of whether or not the
effects were due to the active treatment ingredients or non-specific
factors.
Notwithstanding these limitations, we hold that this paper
makes two main contributions: (1) It shows that several theoreti-
cally meaningful cognitive processes can be ameliorated by both
online and face-to-face CBT-I, and (2) that these cognitive processes
generally mediate the treatment effects. It has yet to be established
which of these specific processes in the Cognitive model of Harvey
[26] is most central. However, we think it firmly stands that the
combination of these cognitive processes plays a major role in the
maintenance of insomnia. This implies that psychological treat-
ments for insomnia may best be guided by (also) targeting these
cognitive processes.
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